Verona Pharma plc 4/A SEC Filings

Filed On	Filing
18 Jun 2025	Form 4/A: Fisher Andrew, General Counsel Received 80,000 shares by exercise or conversion ($161K)
22 May 2025	Form 4/A: Sinha Vikas, Director Received 160,000 shares by exercise or conversion ($225K) · Sold 160,000 shares ($1.43M)
11 May 2023	Form 4/A: Poll Claire, General Counsel Received 8,328 shares by exercise or conversion
11 May 2023	Form 4/A: Rickard Kathleen A., Chief Medical Officer Received 15,000 shares by exercise or conversion

Comments